GlassScriptPhysician profile
Peter S Desilva
NPI 1316045636
$6,484.79
in general payments reported to CMS, 2019-2025
39 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $923 · 2021: $1,021 · 2022: $988 · 2023: $906 · 2024: $786 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,744.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,830.59 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $656.08 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Glaxosmithkline, LLC. | $472.10 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $439.34 | 2019-2024 | Mounjaro, Trulicity, Zepbound |
| Merck Sharp & Dohme LLC | $284.19 | 2019-2025 | Gardasil 9, M-M-R II, Capvaxive |
| Allergan, INC. | $261.03 | 2019-2020 | |
| Amgen INC. | $256.56 | 2019-2025 | Repatha, Otezla, Repatha |
| Amarin Pharma, INC. | $255.06 | 2019-2021 | |
| Pfizer INC. | $218.27 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $198.24 | 2020-2025 | Xifaxan |
| Kowa Pharmaceuticals America, INC. | $165.04 | 2020-2025 | Zoryve |
| Exact Sciences Corporation | $153.23 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $135.15 | 2019-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $107.87 | 2024-2025 | Freestyle Libre 3 |
| Eisai INC. | $104.93 | 2020-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Desilva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.